These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2053 related items for PubMed ID: 29272783

  • 1. Mammography screening: A major issue in medicine.
    Autier P, Boniol M.
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [Abstract] [Full Text] [Related]

  • 2.
    Movik E, Dalsbø TK, Fagelund BC, Friberg EG, Håheim LL, Skår Å.
    ; 2017 09 04. PubMed ID: 29553669
    [Abstract] [Full Text] [Related]

  • 3. Supplemental Screening as an Adjunct to Mammography for Breast Cancer Screening in People With Dense Breasts: A Health Technology Assessment.
    Ontario Health (Quality) .
    Ont Health Technol Assess Ser; 2023 09 04; 23(9):1-293. PubMed ID: 39364436
    [Abstract] [Full Text] [Related]

  • 4. Cancer screening with digital mammography for women at average risk for breast cancer, magnetic resonance imaging (MRI) for women at high risk: an evidence-based analysis.
    Medical Advisory Secretariat.
    Ont Health Technol Assess Ser; 2010 09 04; 10(3):1-55. PubMed ID: 23074406
    [Abstract] [Full Text] [Related]

  • 5.
    Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K.
    ; 2016 01 04. PubMed ID: 26866210
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
    Autier P, Boniol M, Koechlin A, Pizot C, Boniol M.
    BMJ; 2017 Dec 05; 359():j5224. PubMed ID: 29208760
    [Abstract] [Full Text] [Related]

  • 7. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
    Duffy S, Vulkan D, Cuckle H, Parmar D, Sheikh S, Smith R, Evans A, Blyuss O, Johns L, Ellis I, Sasieni P, Wale C, Myles J, Moss S.
    Health Technol Assess; 2020 Oct 05; 24(55):1-24. PubMed ID: 33141657
    [Abstract] [Full Text] [Related]

  • 8. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat.
    Ont Health Technol Assess Ser; 2007 Oct 05; 7(1):1-32. PubMed ID: 23074501
    [Abstract] [Full Text] [Related]

  • 9. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE.
    Radiology; 2018 May 05; 287(2):391-397. PubMed ID: 29267146
    [Abstract] [Full Text] [Related]

  • 10. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
    Welch HG, Prorok PC, O'Malley AJ, Kramer BS.
    N Engl J Med; 2016 Oct 13; 375(15):1438-1447. PubMed ID: 27732805
    [Abstract] [Full Text] [Related]

  • 11. [Tailored Breast Screening Trial (TBST)].
    Paci E, Mantellini P, Giorgi Rossi P, Falini P, Puliti D, TBST Working Group.
    Epidemiol Prev; 2013 Oct 13; 37(4-5):317-27. PubMed ID: 24293498
    [Abstract] [Full Text] [Related]

  • 12.
    Wernli KJ, Henrikson NB, Morrison CC, Nguyen M, Pocobelli G, Whitlock EP.
    ; 2016 07 13. PubMed ID: 27583318
    [Abstract] [Full Text] [Related]

  • 13.
    Nelson HD, Cantor A, Humphrey L, Fu R, Pappas M, Daeges M, Griffin J.
    ; 2016 01 13. PubMed ID: 26889531
    [Abstract] [Full Text] [Related]

  • 14. Responding to the challenges of breast cancer in egypt and other arab countries.
    El Saghir NS.
    J Egypt Natl Canc Inst; 2008 Dec 13; 20(4):309-12. PubMed ID: 20571588
    [Abstract] [Full Text] [Related]

  • 15. Observed and Predicted Risk of Breast Cancer Death in Randomized Trials on Breast Cancer Screening.
    Autier P, Boniol M, Smans M, Sullivan R, Boyle P.
    PLoS One; 2016 Dec 13; 11(4):e0154113. PubMed ID: 27100174
    [Abstract] [Full Text] [Related]

  • 16. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
    Zackrisson S, Lång K, Rosso A, Johnson K, Dustler M, Förnvik D, Förnvik H, Sartor H, Timberg P, Tingberg A, Andersson I.
    Lancet Oncol; 2018 Nov 13; 19(11):1493-1503. PubMed ID: 30322817
    [Abstract] [Full Text] [Related]

  • 17. Long-term relationships between screening rates, breast cancer characteristics, and overdiagnosis in US counties, 1975-2009.
    Harding C, Pompei F, Burmistrov D, Wilson R.
    Int J Cancer; 2019 Feb 01; 144(3):476-488. PubMed ID: 30264887
    [Abstract] [Full Text] [Related]

  • 18. Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.
    Trentham-Dietz A, Chapman CH, Jayasekera J, Lowry KP, Heckman-Stoddard BM, Hampton JM, Caswell-Jin JL, Gangnon RE, Lu Y, Huang H, Stein S, Sun L, Gil Quessep EJ, Yang Y, Lu Y, Song J, Muñoz DF, Li Y, Kurian AW, Kerlikowske K, O'Meara ES, Sprague BL, Tosteson ANA, Feuer EJ, Berry D, Plevritis SK, Huang X, de Koning HJ, van Ravesteyn NT, Lee SJ, Alagoz O, Schechter CB, Stout NK, Miglioretti DL, Mandelblatt JS.
    JAMA; 2024 Jun 11; 331(22):1947-1960. PubMed ID: 38687505
    [Abstract] [Full Text] [Related]

  • 19. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
    Seigneurin A, Labarère J, François O, Exbrayat C, Dupouy M, Filippi M, Colonna M.
    Breast; 2016 Aug 11; 28():60-6. PubMed ID: 27240167
    [Abstract] [Full Text] [Related]

  • 20.
    Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J.
    ; 2018 05 11. PubMed ID: 30085502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 103.